NYSE : ZTS
Zoetis Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 79.65 USD (Oct 30, 2026, 9:47 AM EDT) · Market cap 32.91B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 32.94B |
| Enterprise Value | 40.52B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Oct 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 413.22M |
| Shares Outstanding | 413.22M |
| Shares Change (YoY) | -4.22% |
| Shares Change (QoQ) | -1.11% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 98.47% |
| Float | 412.37M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 13.01 |
| Forward PE | 12.97 |
| PS Ratio | 3.46 |
| Forward PS | 3.57 |
| PB Ratio | 10.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.22 |
| P/OCF Ratio | 11.60 |
| PEG Ratio | 1.24 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 15.37 |
| EV / Sales | 4.25 |
| EV / EBITDA | 9.97 |
| EV / EBIT | 11.16 |
| EV / FCF | 17.50 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.08 |
| Quick Ratio | 1.58 |
| Debt / Equity | 2.94 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 4.00 |
| Interest Coverage | 15.25 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 64.91% |
| Return on Assets (ROA) | 15.35% |
| Return on Invested Capital (ROIC) | 27.28% |
| Return on Capital Employed (ROCE) | 27.89% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | $656,897 |
| Profits Per Employee | $181,862 |
| Employee Count | 14,500 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 1.07 |
Taxes
| Measure | Value |
|---|
| Income Tax | 662.00M |
| Effective Tax Rate | 20.07% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -44.62% |
| 50-Day Moving Average | 75.05 |
| 200-Day Moving Average | 93.53 |
| Relative Strength Index (RSI) | 60.44 |
| Average Volume (20 Days) | 3,768,751 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 17.52M |
| Short Previous Month | 17.39M |
| Short % of Shares Out | 4.24% |
| Short % of Float | 4.25% |
| Short Ratio (days to cover) | 3.99 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 9.53B |
| Gross Profit | 6.83B |
| Operating Income | 3.63B |
| Pretax Income | 3.30B |
| Net Income | 2.64B |
| EBITDA | 4.07B |
| EBIT | 3.63B |
| Earnings Per Share (EPS) | $6.13 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.68B |
| Total Debt | 9.26B |
| Net Cash | -7.58B |
| Net Cash Per Share | -$18.34 |
| Equity (Book Value) | 3.15B |
| Book Value Per Share | 7.60 |
| Working Capital | 4.30B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 2.84B |
| Capital Expenditures | -524.00M |
| Depreciation & Amortization | 436.00M |
| Net Borrowing | 2.31B |
| Free Cash Flow | 2.32B |
| FCF Per Share | $5.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.74% |
| Operating Margin | 38.11% |
| Pretax Margin | 34.64% |
| Profit Margin | 27.69% |
| EBITDA Margin | 42.69% |
| EBIT Margin | 38.11% |
| FCF Margin | 24.31% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.12 |
| Dividend Yield | 2.66% |
| Dividend Growth (YoY) | 6.00% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 34.59% |
| FCF Payout Ratio | 37.83% |
| Buyback Yield | 4.22% |
| Shareholder Yield | 6.88% |
| Earnings Yield | 7.69% |
| FCF Yield | 7.03% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $88.38 |
| Price Target Difference | 10.86% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 0.78% |
| EPS Growth Forecast (3Y) | 2.35% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.87 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |